Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 500 results in range #1 to #500.

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)

  1. Non-malignant skin disease‏‎ (478 revisions)
  2. Main Page‏‎ (406 revisions)
  3. Kidney tumours‏‎ (402 revisions)
  4. Neuropathology tumours‏‎ (398 revisions)
  5. Stomach‏‎ (381 revisions)
  6. Placenta‏‎ (355 revisions)
  7. Neuropathology‏‎ (343 revisions)
  8. Breast pathology‏‎ (332 revisions)
  9. Medical kidney diseases‏‎ (329 revisions)
  10. Gastrointestinal tract polyps‏‎ (322 revisions)
  11. Uterine cervix‏‎ (315 revisions)
  12. Prostate gland‏‎ (309 revisions)
  13. Dermatologic neoplasms‏‎ (301 revisions)
  14. Ditzels‏‎ (297 revisions)
  15. Invasive breast cancer‏‎ (291 revisions)
  16. Medical liver disease‏‎ (289 revisions)
  17. Colon‏‎ (287 revisions)
  18. Forensic pathology‏‎ (279 revisions)
  19. Endometrium‏‎ (270 revisions)
  20. Chondro-osseous tumours‏‎ (268 revisions)
  21. Esophagus‏‎ (265 revisions)
  22. Prostate cancer‏‎ (263 revisions)
  23. Ovarian tumours‏‎ (256 revisions)
  24. Melanocytic lesions‏‎ (246 revisions)
  25. Soft tissue lesions‏‎ (245 revisions)
  26. Pancreas‏‎ (244 revisions)
  27. Testis‏‎ (232 revisions)
  28. An introduction to head and neck pathology‏‎ (232 revisions)
  29. Salivary glands‏‎ (231 revisions)
  30. Medical lung diseases‏‎ (225 revisions)
  31. Urothelium‏‎ (213 revisions)
  32. Lymph node pathology‏‎ (212 revisions)
  33. Thyroid gland‏‎ (211 revisions)
  34. Duodenum‏‎ (198 revisions)
  35. Gynecologic cytopathology‏‎ (192 revisions)
  36. Dermatopathology‏‎ (190 revisions)
  37. Stains‏‎ (186 revisions)
  38. Basics‏‎ (186 revisions)
  39. Long power list‏‎ (181 revisions)
  40. Inflammatory bowel disease‏‎ (175 revisions)
  41. Liver neoplasms‏‎ (173 revisions)
  42. Lung tumours‏‎ (169 revisions)
  43. Inflammatory skin disorders‏‎ (167 revisions)
  44. Autopsy‏‎ (154 revisions)
  45. Neuromuscular pathology‏‎ (153 revisions)
  46. Immunohistochemical staining‏‎ (153 revisions)
  47. Uterine tumours‏‎ (153 revisions)
  48. Adrenal gland‏‎ (152 revisions)
  49. Neurodegenerative diseases‏‎ (151 revisions)
  50. Eye‏‎ (144 revisions)
  51. Fibroblastic/myofibroblastic tumours‏‎ (143 revisions)
  52. Lymphoma‏‎ (140 revisions)
  53. Liver pathology‏‎ (138 revisions)
  54. Colorectal tumours‏‎ (135 revisions)
  55. Malignant melanoma‏‎ (135 revisions)
  56. Peripheral nerve sheath tumours‏‎ (133 revisions)
  57. Vulva‏‎ (132 revisions)
  58. Gallbladder‏‎ (130 revisions)
  59. Heart valves‏‎ (127 revisions)
  60. Gestational trophoblastic disease‏‎ (125 revisions)
  61. Germ cell tumours‏‎ (119 revisions)
  62. Heart‏‎ (116 revisions)
  63. Vermiform appendix‏‎ (113 revisions)
  64. Bone‏‎ (112 revisions)
  65. Dermal cysts‏‎ (112 revisions)
  66. Vasculitides‏‎ (108 revisions)
  67. Endometrial carcinoma‏‎ (108 revisions)
  68. Microorganisms‏‎ (108 revisions)
  69. Small intestine‏‎ (103 revisions)
  70. Meningioma‏‎ (102 revisions)
  71. Adipocytic tumours‏‎ (102 revisions)
  72. Small cell lymphomas‏‎ (101 revisions)
  73. Cases‏‎ (100 revisions)
  74. Pathology links‏‎ (100 revisions)
  75. Vascular disease‏‎ (97 revisions)
  76. Adenocarcinoma of the lung‏‎ (93 revisions)
  77. Amyloid‏‎ (92 revisions)
  78. Pituitary gland‏‎ (91 revisions)
  79. Diffuse lung diseases‏‎ (91 revisions)
  80. Vascular tumours‏‎ (90 revisions)
  81. An introduction to gynecologic pathology‏‎ (89 revisions)
  82. Pulmonary cytopathology‏‎ (89 revisions)
  83. Short power list‏‎ (88 revisions)
  84. Non-invasive breast carcinoma‏‎ (87 revisions)
  85. Fungi‏‎ (86 revisions)
  86. Urothelial carcinoma‏‎ (85 revisions)
  87. Celiac sprue‏‎ (83 revisions)
  88. Parathyroid glands‏‎ (82 revisions)
  89. Neurohistology‏‎ (82 revisions)
  90. Spleen‏‎ (79 revisions)
  91. Cytopathology‏‎ (79 revisions)
  92. Pulmonary pathology‏‎ (78 revisions)
  93. Surgical margins‏‎ (75 revisions)
  94. Thyroid cytopathology‏‎ (74 revisions)
  95. Quality‏‎ (71 revisions)
  96. Pediatric gastrointestinal pathology‏‎ (70 revisions)
  97. Colorectal adenocarcinoma‏‎ (70 revisions)
  98. MEDITECH‏‎ (70 revisions)
  99. Viruses‏‎ (70 revisions)
  100. Mesothelial cytopathology‏‎ (70 revisions)
  101. Libre Pathology‏‎ (69 revisions)
  102. Products of conception‏‎ (68 revisions)
  103. Bacteria‏‎ (67 revisions)
  104. Haematopathology‏‎ (67 revisions)
  105. Papillary renal cell carcinoma‏‎ (67 revisions)
  106. Uterine tubes‏‎ (66 revisions)
  107. Endometrial hyperplasia‏‎ (66 revisions)
  108. Asphyxial deaths‏‎ (66 revisions)
  109. Gross pathology‏‎ (65 revisions)
  110. Penis‏‎ (65 revisions)
  111. Traditional adenoma‏‎ (65 revisions)
  112. Spot diagnoses‏‎ (65 revisions)
  113. Molecular pathology‏‎ (62 revisions)
  114. Thymus‏‎ (62 revisions)
  115. Gastrointestinal stromal tumour‏‎ (62 revisions)
  116. Anus‏‎ (62 revisions)
  117. Oral pathology‏‎ (62 revisions)
  118. Uterus‏‎ (62 revisions)
  119. Clear cell renal cell carcinoma‏‎ (61 revisions)
  120. Bullous diseases‏‎ (61 revisions)
  121. Squamous cell carcinoma‏‎ (61 revisions)
  122. Hodgkin lymphoma‏‎ (60 revisions)
  123. Extramammary Paget disease‏‎ (60 revisions)
  124. Femoral head‏‎ (60 revisions)
  125. Small round cell tumours‏‎ (59 revisions)
  126. Rheumatoid arthritis‏‎ (59 revisions)
  127. Chondrosarcoma‏‎ (59 revisions)
  128. Odontogenic tumours and cysts‏‎ (58 revisions)
  129. Pediatric pathology‏‎ (58 revisions)
  130. Vas deferens‏‎ (58 revisions)
  131. LP:Sandbox‏‎ (57 revisions)
  132. Head and neck cytopathology‏‎ (57 revisions)
  133. Hereditary leiomyomatosis and renal cell carcinoma syndrome‏‎ (57 revisions)
  134. Succinate dehydrogenase-deficient renal cell carcinoma‏‎ (56 revisions)
  135. Angiomyolipoma‏‎ (55 revisions)
  136. Cardiac tumours‏‎ (55 revisions)
  137. Metastases‏‎ (54 revisions)
  138. Sertoli-Leydig cell tumour‏‎ (54 revisions)
  139. An introduction to gastrointestinal pathology‏‎ (54 revisions)
  140. Endometriosis‏‎ (54 revisions)
  141. Spindle cell lesions‏‎ (54 revisions)
  142. Diffuse large B-cell lymphoma‏‎ (54 revisions)
  143. Non-small cell lung carcinoma‏‎ (53 revisions)
  144. Clinical history‏‎ (53 revisions)
  145. Trophoblast‏‎ (53 revisions)
  146. Prostate cancer grading‏‎ (52 revisions)
  147. Urinary bladder‏‎ (52 revisions)
  148. Intracranial hematomas‏‎ (52 revisions)
  149. Clear cell papillary renal cell tumour‏‎ (51 revisions)
  150. Crystals in body fluids‏‎ (51 revisions)
  151. Renal oncocytoma‏‎ (50 revisions)
  152. Gastrointestinal cytopathology‏‎ (50 revisions)
  153. Intraoperative consultation‏‎ (50 revisions)
  154. Osteoarthritis‏‎ (50 revisions)
  155. Ampulla of Vater‏‎ (49 revisions)
  156. Tuberous sclerosis‏‎ (49 revisions)
  157. Malignant mesothelioma‏‎ (49 revisions)
  158. Neuroendocrine neoplasms‏‎ (48 revisions)
  159. Pheochromocytoma‏‎ (48 revisions)
  160. TFE3-rearranged renal cell carcinoma‏‎ (47 revisions)
  161. Congenital heart disease‏‎ (47 revisions)
  162. L4E rule 1-3 (2014)‏‎ (47 revisions)
  163. Chromophobe renal cell carcinoma‏‎ (47 revisions)
  164. Granular cell tumour‏‎ (46 revisions)
  165. Hypertension‏‎ (45 revisions)
  166. Astrocytoma‏‎ (45 revisions)
  167. Pulmonary embolism‏‎ (45 revisions)
  168. Urine cytopathology‏‎ (45 revisions)
  169. Gunshot wounds‏‎ (45 revisions)
  170. Rhabdomyosarcoma‏‎ (45 revisions)
  171. Chromosomal translocations‏‎ (44 revisions)
  172. TFEB-rearranged renal cell carcinoma‏‎ (44 revisions)
  173. Breast cytopathology‏‎ (44 revisions)
  174. Desmoid-type fibromatosis‏‎ (44 revisions)
  175. Craniopharyngioma‏‎ (43 revisions)
  176. Diverticular disease‏‎ (43 revisions)
  177. Joints‏‎ (43 revisions)
  178. Familial adenomatous polyposis‏‎ (43 revisions)
  179. ELOC-mutated renal cell carcinoma‏‎ (42 revisions)
  180. Sarcoidosis‏‎ (42 revisions)
  181. Basal cell carcinoma‏‎ (42 revisions)
  182. OP:Sandbox3‏‎ (42 revisions)
  183. SMARCB1-deficient renal medullary carcinoma‏‎ (42 revisions)
  184. Secretory carcinoma of the salivary gland‏‎ (42 revisions)
  185. Level 4 equivalent of 2014‏‎ (42 revisions)
  186. Renal mucinous tubular and spindle cell carcinoma‏‎ (42 revisions)
  187. Seminoma‏‎ (42 revisions)
  188. Mucinous carcinoma‏‎ (42 revisions)
  189. Renal tumours with eosinophilic cytoplasm‏‎ (41 revisions)
  190. Leiomyoma‏‎ (41 revisions)
  191. Ependymoma‏‎ (41 revisions)
  192. Lymph node metastasis‏‎ (41 revisions)
  193. Small cell carcinoma‏‎ (41 revisions)
  194. Informatics‏‎ (40 revisions)
  195. Sjögren syndrome‏‎ (40 revisions)
  196. Signet ring cell carcinoma‏‎ (40 revisions)
  197. Nephrogenic adenoma‏‎ (40 revisions)
  198. Giant cell arteritis‏‎ (39 revisions)
  199. Programmed death-ligand 1‏‎ (39 revisions)
  200. Hyperplastic polyp‏‎ (39 revisions)
  201. P16‏‎ (39 revisions)
  202. Cystic kidney diseases‏‎ (39 revisions)
  203. Nephrotic syndrome‏‎ (38 revisions)
  204. Papillary thyroid carcinoma‏‎ (38 revisions)
  205. Lymphovascular invasion‏‎ (38 revisions)
  206. Seborrheic keratosis‏‎ (38 revisions)
  207. Acquired cystic disease-associated renal cell carcinoma‏‎ (38 revisions)
  208. Leukemia‏‎ (38 revisions)
  209. Robbins and Cotran 9th Edition Questions‏‎ (38 revisions)
  210. Glomus tumour‏‎ (37 revisions)
  211. Cardiomyopathy‏‎ (37 revisions)
  212. Metaphyseal fibrous defect‏‎ (37 revisions)
  213. Neurofibromatosis‏‎ (37 revisions)
  214. Schwannoma‏‎ (37 revisions)
  215. Total nephrectomy for tumour grossing‏‎ (36 revisions)
  216. Serous carcinoma of the ovary‏‎ (36 revisions)
  217. NUT carcinoma‏‎ (36 revisions)
  218. Pneumonia‏‎ (36 revisions)
  219. Prostate-specific antigen‏‎ (35 revisions)
  220. Lymph nodes‏‎ (35 revisions)
  221. Helicobacter gastritis‏‎ (35 revisions)
  222. Renal angiomyoadenomatous tumour‏‎ (35 revisions)
  223. Heart transplant pathology‏‎ (34 revisions)
  224. Medullary thyroid carcinoma‏‎ (34 revisions)
  225. Cancer staging systems‏‎ (34 revisions)
  226. Thrombotic microangiopathy‏‎ (34 revisions)
  227. Low-grade oncocytic renal tumour‏‎ (34 revisions)
  228. Steatohepatitis‏‎ (34 revisions)
  229. GATA3‏‎ (34 revisions)
  230. Renal transplant pathology‏‎ (34 revisions)
  231. Sessile serrated adenoma‏‎ (33 revisions)
  232. Langerhans cell histiocytosis‏‎ (33 revisions)
  233. Squamous cell carcinoma of the lung‏‎ (33 revisions)
  234. Acinic cell carcinoma‏‎ (33 revisions)
  235. Twin placentas‏‎ (33 revisions)
  236. Cervical polyps‏‎ (33 revisions)
  237. Intraductal carcinoma of the prostate‏‎ (33 revisions)
  238. Squamous cell carcinoma of the head and neck‏‎ (33 revisions)
  239. Fibromatoses‏‎ (33 revisions)
  240. Gastritis‏‎ (33 revisions)
  241. Multiple endocrine neoplasia‏‎ (33 revisions)
  242. Pulmonary alveolar proteinosis‏‎ (33 revisions)
  243. Typical carcinoid lung tumour‏‎ (33 revisions)
  244. Ovary‏‎ (32 revisions)
  245. Fetal autopsy‏‎ (32 revisions)
  246. Glioblastoma‏‎ (32 revisions)
  247. Esophageal adenocarcinoma‏‎ (32 revisions)
  248. Intranodal palisaded myofibroblastoma‏‎ (32 revisions)
  249. Urothelial dysplasia‏‎ (32 revisions)
  250. Principles of gross pathology‏‎ (32 revisions)
  251. Radiation changes‏‎ (31 revisions)
  252. Plasma cell neoplasms‏‎ (31 revisions)
  253. Granuloma‏‎ (31 revisions)
  254. Microphotography‏‎ (31 revisions)
  255. Adenocarcinoma of the urinary bladder‏‎ (31 revisions)
  256. Sarcoma with CIC-rearrangement‏‎ (31 revisions)
  257. Small cell carcinoma of the lung‏‎ (31 revisions)
  258. Critical values‏‎ (31 revisions)
  259. Lynch syndrome‏‎ (31 revisions)
  260. Chordoma‏‎ (31 revisions)
  261. Oligodendroglioma‏‎ (31 revisions)
  262. Lung cancer staging‏‎ (31 revisions)
  263. Paraganglioma‏‎ (31 revisions)
  264. Nasopharyngeal carcinoma‏‎ (31 revisions)
  265. Micropapillary urothelial carcinoma‏‎ (30 revisions)
  266. Colorectal cancer staging‏‎ (30 revisions)
  267. Orchiectomy grossing‏‎ (30 revisions)
  268. Pediatric kidney tumours‏‎ (30 revisions)
  269. Cytogenetics Review Questions‏‎ (30 revisions)
  270. Programmed cell death 1‏‎ (30 revisions)
  271. Urachal carcinoma‏‎ (30 revisions)
  272. Pleomorphic adenoma‏‎ (30 revisions)
  273. Pineal gland‏‎ (30 revisions)
  274. Leiomyosarcoma‏‎ (30 revisions)
  275. Breast grossing‏‎ (30 revisions)
  276. Pathology reports‏‎ (30 revisions)
  277. Cartilage‏‎ (30 revisions)
  278. Mucoepidermoid carcinoma‏‎ (29 revisions)
  279. Cystic tumour of the atrioventricular nodal region‏‎ (29 revisions)
  280. Hemophagocytic syndrome‏‎ (29 revisions)
  281. Lung carcinoma with ALK rearrangement‏‎ (29 revisions)
  282. Yolk sac tumour‏‎ (29 revisions)
  283. Teratoma‏‎ (29 revisions)
  284. Tubulocystic carcinoma of the kidney‏‎ (29 revisions)
  285. ALK translocation renal cell carcinoma‏‎ (29 revisions)
  286. Multilocular cystic renal neoplasm of low malignant potential‏‎ (29 revisions)
  287. Adenoid cystic carcinoma‏‎ (29 revisions)
  288. Libre Pathology news‏‎ (28 revisions)
  289. Vagina‏‎ (28 revisions)
  290. TRK fusions‏‎ (28 revisions)
  291. Wilms tumour‏‎ (28 revisions)
  292. Peritoneum‏‎ (28 revisions)
  293. Urothelial carcinoma in situ‏‎ (28 revisions)
  294. Squamous cell carcinoma of the skin‏‎ (28 revisions)
  295. Embryonal carcinoma‏‎ (28 revisions)
  296. Quiz:L4E uropathology (2014)‏‎ (28 revisions)
  297. Warthin tumour‏‎ (28 revisions)
  298. Acute appendicitis‏‎ (28 revisions)
  299. CSF cytopathology‏‎ (28 revisions)
  300. Waffle diagnosis‏‎ (28 revisions)
  301. Pneumocytoma‏‎ (27 revisions)
  302. Anastomosing hemangioma of the kidney‏‎ (27 revisions)
  303. Burkitt lymphoma‏‎ (27 revisions)
  304. Zoon vulvitis‏‎ (27 revisions)
  305. Neuroanatomy‏‎ (27 revisions)
  306. End-stage kidney‏‎ (27 revisions)
  307. Polymorphous adenocarcinoma‏‎ (27 revisions)
  308. Pathology requisitions‏‎ (27 revisions)
  309. Cystoprostatectomy grossing‏‎ (27 revisions)
  310. Molecular pathology tests‏‎ (27 revisions)
  311. Mucinous cystadenoma of the ovary‏‎ (26 revisions)
  312. Ileocecal valve‏‎ (26 revisions)
  313. Starvation‏‎ (26 revisions)
  314. Cytogenetics‏‎ (26 revisions)
  315. Pseudomembranous colitis‏‎ (26 revisions)
  316. Adrenocortical carcinoma‏‎ (26 revisions)
  317. Granulomatous prostatitis‏‎ (26 revisions)
  318. Squamous cell carcinoma of the penis‏‎ (26 revisions)
  319. KRAS mutation‏‎ (26 revisions)
  320. Leydig cell tumour‏‎ (26 revisions)
  321. Neuroendocrine tumour of the pancreas‏‎ (26 revisions)
  322. Angiosarcoma‏‎ (26 revisions)
  323. Sudden natural death‏‎ (26 revisions)
  324. Goblet cell adenocarcinoma‏‎ (25 revisions)
  325. Brenner tumour‏‎ (25 revisions)
  326. Classification of urothelial carcinoma by immunohistochemistry‏‎ (25 revisions)
  327. Cancer‏‎ (25 revisions)
  328. Complex endometrial hyperplasia‏‎ (25 revisions)
  329. Case:Blank‏‎ (25 revisions)
  330. Serous cystadenoma of the ovary‏‎ (25 revisions)
  331. Mixed germ cell tumour‏‎ (25 revisions)
  332. Foreign material‏‎ (25 revisions)
  333. Prostate cancer staging‏‎ (25 revisions)
  334. Parathyroid hyperplasia‏‎ (25 revisions)
  335. Autosomal dominant polycystic kidney disease‏‎ (25 revisions)
  336. Atypical teratoid/rhabdoid tumour‏‎ (25 revisions)
  337. Medulloblastoma‏‎ (25 revisions)
  338. Carcinoma ex pleomorphic adenoma‏‎ (25 revisions)
  339. Pleural invasion‏‎ (25 revisions)
  340. Tuberous sclerosis-associated renal cell carcinoma‏‎ (25 revisions)
  341. Fecal material‏‎ (25 revisions)
  342. Rosai-Dorfman disease‏‎ (24 revisions)
  343. Cystic nephroma, adult type‏‎ (24 revisions)
  344. Crohn's disease‏‎ (24 revisions)
  345. Psammoma bodies‏‎ (24 revisions)
  346. L4E rule 7-8 (2014)‏‎ (24 revisions)
  347. Large epithelioid tumours‏‎ (24 revisions)
  348. Pathology for medical students‏‎ (24 revisions)
  349. Germ cell neoplasia in situ‏‎ (24 revisions)
  350. Parathyroid adenoma‏‎ (24 revisions)
  351. Von Hippel-Lindau disease‏‎ (24 revisions)
  352. Adenocarcinoma‏‎ (24 revisions)
  353. Panniculitis‏‎ (24 revisions)
  354. Eccrine spiradenoma‏‎ (24 revisions)
  355. Clear cell carcinoma‏‎ (24 revisions)
  356. Necrosis‏‎ (24 revisions)
  357. Prostatic stromal tumour of uncertain malignant potential‏‎ (24 revisions)
  358. Renal hybrid oncocytic/chromophobe tumour‏‎ (24 revisions)
  359. Hemangioma‏‎ (24 revisions)
  360. Biphenotypic sinonasal sarcoma‏‎ (24 revisions)
  361. Barrett's esophagus‏‎ (23 revisions)
  362. Choriocarcinoma‏‎ (23 revisions)
  363. Lymphoepithelioma-like carcinoma of the urinary bladder‏‎ (23 revisions)
  364. Chondromyxoid fibroma‏‎ (23 revisions)
  365. Desquamative interstitial pneumonia‏‎ (23 revisions)
  366. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features‏‎ (23 revisions)
  367. Stomach carcinoma‏‎ (23 revisions)
  368. Endometrioid endometrial carcinoma‏‎ (23 revisions)
  369. Epithelioid hemangioendothelioma‏‎ (23 revisions)
  370. In-transit metastasis‏‎ (23 revisions)
  371. Squamous cell carcinoma of the urinary bladder‏‎ (23 revisions)
  372. Apocrine carcinoma of the breast‏‎ (23 revisions)
  373. Sarcina‏‎ (23 revisions)
  374. Anatomical pathology laboratory processes‏‎ (23 revisions)
  375. Course:Introduction to Neuropathology‏‎ (23 revisions)
  376. Syphilis‏‎ (23 revisions)
  377. Nodular hyperplasia of the prostate gland‏‎ (23 revisions)
  378. Pulmonary hypertension‏‎ (23 revisions)
  379. Squamous intraepithelial lesion of the uterine cervix‏‎ (23 revisions)
  380. Pseudomelanosis coli‏‎ (22 revisions)
  381. Pilocytic astrocytoma‏‎ (22 revisions)
  382. Histology artifacts‏‎ (22 revisions)
  383. Electron microscopy‏‎ (22 revisions)
  384. Leydig cell hyperplasia‏‎ (22 revisions)
  385. Metanephric adenoma‏‎ (22 revisions)
  386. Brain metastasis‏‎ (22 revisions)
  387. Renal oncocytosis‏‎ (22 revisions)
  388. Vascular malformations‏‎ (22 revisions)
  389. Diagnosis‏‎ (22 revisions)
  390. Small bowel pseudomelanosis‏‎ (22 revisions)
  391. Pulmonary blastoma‏‎ (22 revisions)
  392. Hepatocellular carcinoma‏‎ (22 revisions)
  393. Malakoplakia‏‎ (22 revisions)
  394. Smoking‏‎ (22 revisions)
  395. Follicular dendritic cell sarcoma‏‎ (22 revisions)
  396. Adamantinoma‏‎ (22 revisions)
  397. Atypical adenomatous hyperplasia of the lung‏‎ (22 revisions)
  398. Cribriform adenocarcinoma of the minor salivary gland‏‎ (22 revisions)
  399. Proliferative phase endometrium‏‎ (22 revisions)
  400. Liver metastasis‏‎ (22 revisions)
  401. Plasma cell‏‎ (22 revisions)
  402. Fibroadenoma‏‎ (22 revisions)
  403. Diagnostic size cutoffs‏‎ (21 revisions)
  404. Gout‏‎ (21 revisions)
  405. Eosinophilic esophagitis‏‎ (21 revisions)
  406. Papillary cystadenoma of the epididymis‏‎ (21 revisions)
  407. Pressure ulcer‏‎ (21 revisions)
  408. IgG4-related systemic diseases‏‎ (21 revisions)
  409. Fundic gland polyp‏‎ (21 revisions)
  410. Red blood cell‏‎ (21 revisions)
  411. Autoimmune hepatitis‏‎ (21 revisions)
  412. Lichen sclerosus‏‎ (21 revisions)
  413. Histiocytoses‏‎ (21 revisions)
  414. Light microscopy‏‎ (21 revisions)
  415. SMARCB1‏‎ (21 revisions)
  416. Thyroid imaging reporting and data system‏‎ (21 revisions)
  417. Lymphocytic colitis‏‎ (21 revisions)
  418. Systemic lupus erythematosus‏‎ (21 revisions)
  419. Human immunodeficiency virus‏‎ (21 revisions)
  420. Sinonasal undifferentiated carcinoma‏‎ (21 revisions)
  421. Loop electrosurgical excision procedure‏‎ (21 revisions)
  422. Multifocal micronodular pneumocyte hyperplasia associated with tuberous sclerosis‏‎ (21 revisions)
  423. Intestinal metaplasia of the stomach‏‎ (21 revisions)
  424. Immune thrombocytopenic purpura‏‎ (21 revisions)
  425. Reactive gastropathy‏‎ (21 revisions)
  426. Prostate chips grossing‏‎ (21 revisions)
  427. Adenocarcinoma of the rete testis‏‎ (21 revisions)
  428. Lymphangioleiomyomatosis‏‎ (21 revisions)
  429. Abusive head trauma‏‎ (21 revisions)
  430. Salivary duct carcinoma‏‎ (21 revisions)
  431. Case 1‏‎ (21 revisions)
  432. Parathyroid carcinoma‏‎ (21 revisions)
  433. Chondroblastoma‏‎ (20 revisions)
  434. Porocarcinoma‏‎ (20 revisions)
  435. Usual interstitial pneumonia‏‎ (20 revisions)
  436. Acute cholecystitis‏‎ (20 revisions)
  437. Phosphaturic mesenchymal tumour, mixed connective tissue type‏‎ (20 revisions)
  438. Follicular lymphoma‏‎ (20 revisions)
  439. Invasive ductal carcinoma of the breast‏‎ (20 revisions)
  440. Nasal polyps‏‎ (20 revisions)
  441. Ganglioglioma‏‎ (20 revisions)
  442. Hepatocyte nuclear factor-1beta‏‎ (20 revisions)
  443. Radical cystectomy grossing‏‎ (20 revisions)
  444. Giant cells‏‎ (20 revisions)
  445. Hepatitis B‏‎ (20 revisions)
  446. Juxtaglomerular cell tumour‏‎ (20 revisions)
  447. High-grade prostatic intraepithelial neoplasia‏‎ (20 revisions)
  448. Avascular necrosis of the femoral head‏‎ (20 revisions)
  449. Lymph node grossing‏‎ (20 revisions)
  450. Intestinal metaplasia of the gallbladder‏‎ (20 revisions)
  451. Reactive changes‏‎ (20 revisions)
  452. Kidney cancer staging‏‎ (20 revisions)
  453. Case 2‏‎ (20 revisions)
  454. Low-grade squamous intraepithelial lesion‏‎ (20 revisions)
  455. High-grade papillary urothelial carcinoma‏‎ (20 revisions)
  456. Cholangiocarcinoma‏‎ (20 revisions)
  457. Fibrous dysplasia‏‎ (20 revisions)
  458. Hereditary breast cancer‏‎ (20 revisions)
  459. Ischemic colitis‏‎ (19 revisions)
  460. Schmorl's node‏‎ (19 revisions)
  461. Traditional serrated adenoma‏‎ (19 revisions)
  462. Omentum‏‎ (19 revisions)
  463. Tumour budding‏‎ (19 revisions)
  464. Xanthogranulomatous cholecystitis‏‎ (19 revisions)
  465. Gaucher disease‏‎ (19 revisions)
  466. Miscellaneous ovarian tumours‏‎ (19 revisions)
  467. Paired box gene 8‏‎ (19 revisions)
  468. Epidermal necrosis‏‎ (19 revisions)
  469. Tissue fixation‏‎ (19 revisions)
  470. Keratinising squamous metaplasia of the urinary bladder‏‎ (19 revisions)
  471. Case 47‏‎ (19 revisions)
  472. Carbonic anhydrase 9‏‎ (19 revisions)
  473. Colitis cystica profunda‏‎ (19 revisions)
  474. Pityriasis rubra pilaris‏‎ (19 revisions)
  475. CoPath‏‎ (19 revisions)
  476. Small vessel leukocytoclastic vasculitis‏‎ (19 revisions)
  477. Colorectal xanthomatous polyp‏‎ (19 revisions)
  478. MUTYH polyposis syndrome‏‎ (19 revisions)
  479. Invasive ductal carcinoma of the pancreas‏‎ (19 revisions)
  480. Foregut primary carcinomas‏‎ (19 revisions)
  481. Xanthogranulomatous pyelonephritis‏‎ (19 revisions)
  482. Bizarre parosteal osteochondromatous proliferation‏‎ (19 revisions)
  483. Renal cell carcinoma with sarcomatoid differentiation‏‎ (19 revisions)
  484. Mucinous tumours of the appendix‏‎ (19 revisions)
  485. Human papillomavirus-associated head and neck squamous cell carcinoma‏‎ (18 revisions)
  486. Pulmonary carcinoid tumourlet‏‎ (18 revisions)
  487. Penile intraepithelial neoplasia‏‎ (18 revisions)
  488. Case:Notes‏‎ (18 revisions)
  489. Actinic keratosis‏‎ (18 revisions)
  490. Pulmonary hamartoma‏‎ (18 revisions)
  491. Kimura disease‏‎ (18 revisions)
  492. Intraductal papilloma of the breast‏‎ (18 revisions)
  493. Mesenchymal chondrosarcoma‏‎ (18 revisions)
  494. C-cell hyperplasia‏‎ (18 revisions)
  495. Spine‏‎ (18 revisions)
  496. Inflammatory myofibroblastic tumour‏‎ (18 revisions)
  497. Neurofibroma‏‎ (18 revisions)
  498. Eosinophilic vacuolated tumour‏‎ (18 revisions)
  499. Malignant peripheral nerve sheath tumour‏‎ (18 revisions)
  500. Carney complex‏‎ (18 revisions)

View (previous 500 | next 500) (20 | 50 | 100 | 250 | 500)